BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15855508)

  • 1. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
    McAleese F; Petersen P; Ruzin A; Dunman PM; Murphy E; Projan SJ; Bradford PA
    Antimicrob Agents Chemother; 2005 May; 49(5):1865-71. PubMed ID: 15855508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein.
    Kaatz GW; McAleese F; Seo SM
    Antimicrob Agents Chemother; 2005 May; 49(5):1857-64. PubMed ID: 15855507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein.
    Kaatz GW; DeMarco CE; Seo SM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1276-81. PubMed ID: 16569840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.
    Dabul ANG; Avaca-Crusca JS; Van Tyne D; Gilmore MS; Camargo ILBC
    Microb Drug Resist; 2018 Jun; 24(5):519-526. PubMed ID: 29039719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
    Opperman TJ; Williams JD; Houseweart C; Panchal RG; Bavari S; Peet NP; Moir DT; Bowlin TL
    Bioorg Med Chem; 2010 Mar; 18(6):2123-2130. PubMed ID: 20188576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of Staphylococcus aureus.
    Birukou I; Tonthat NK; Seo SM; Schindler BD; Kaatz GW; Brennan RG
    mBio; 2013 Aug; 4(5):e00528-13. PubMed ID: 23982071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus.
    Fang R; Sun Y; Dai W; Zheng X; Tian X; Zhang X; Wang C; Cao J; Zhou T
    J Glob Antimicrob Resist; 2020 Sep; 22():631-636. PubMed ID: 32590185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus.
    Huang H; Wan P; Luo X; Lu Y; Li X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Aug; 11(4):e0063423. PubMed ID: 37432114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes associated with tigecycline resistance in Staphylococcus aureus in vitro-selected mutants belonging to different lineages.
    Herrera M; Gregorio SD; Haim MS; Posse G; Mollerach M; Di Conza J
    Int J Antimicrob Agents; 2021 Apr; 57(4):106304. PubMed ID: 33588015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
    Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
    Linkevicius M; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
    DeMarco CE; Cushing LA; Frempong-Manso E; Seo SM; Jaravaza TA; Kaatz GW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3235-9. PubMed ID: 17576828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of substitution mutations in MepR, a repressor of the Staphylococcus aureus MepA multidrug efflux pump gene.
    Schindler BD; Seo SM; Jacinto PL; Kumaraswami M; Birukou I; Brennan RG; Kaatz GW
    J Bacteriol; 2013 Aug; 195(16):3651-62. PubMed ID: 23749979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
    Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
    J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
    Fluit AC; Florijn A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
    Peleg AY; Adams J; Paterson DL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.